HAVN Life Sciences Inc.
Havn Life Sciences is a biotechnology company on a mission to unlock human potential using evidence-informed research. The Company is focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi, and the development of natural health care products from non-regulated compounds. Learn more at: havnlife.com and follow us on Facebook, Twitter and Instagram.
HAVN Life Sciences Inc. (HAVN)
Le 2 août/August 2022
HAVN Life Sciences Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every thirty (30) pre-consolidated common shares.
As a result, the outstanding shares of the company will be reduced to approximately 5,109,665 common shares.
The name and symbol will not change.